Sign up to save your podcasts
Or
Share How Scientists Are Increasing Antidepressant Effectiveness To Better Treat Depression. FPS #1
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
How Scientists Are Increasing Antidepressant Effectiveness To Better Treat Depression. FPS #1
In this inaugural release of First-Person Science, Roger Hudson speaks with Thomas Lapointe about his recently published manuscript that explores the behavioural and brain mRNA effects of combined escitalopram (an SSRI; antidepressant) and adjunct aripiprazole (5-HT1a agonist) in rats, with a specific focus on the 5-HT1a receptor. This podcast also discusses how scientists are enhancing the therapeutic efficacy of antidepressants and some of the mechanisms involved. "Effects of combined escitalopram and aripiprazole in rats: role of the 5-HT1a receptor", published in Psychopharmacology: https://link.springer.com/article/10.1007/s00213-019-05225-z
View all episodes
In this inaugural release of First-Person Science, Roger Hudson speaks with Thomas Lapointe about his recently published manuscript that explores the behavioural and brain mRNA effects of combined escitalopram (an SSRI; antidepressant) and adjunct aripiprazole (5-HT1a agonist) in rats, with a specific focus on the 5-HT1a receptor. This podcast also discusses how scientists are enhancing the therapeutic efficacy of antidepressants and some of the mechanisms involved. "Effects of combined escitalopram and aripiprazole in rats: role of the 5-HT1a receptor", published in Psychopharmacology: https://link.springer.com/article/10.1007/s00213-019-05225-z